Skip to main content
logo
Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
2.330
+0.200 (9.39%)
Oct 19, 2026, 11:46 AM EDT - Market open

Zentalis Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-139.55-137.06-165.84-292.19-236.81-158.73
Depreciation & Amortization
0.620.741.291.391.430.54
Loss (Gain) From Sale of Assets
-0.13-0.66-0.090.410.06-49.92
Asset Writedown & Restructuring Costs
2.984.143.7420-8.8
Loss (Gain) From Sale of Investments
-4.84-4-13.23-13.16-3.730.91
Loss (Gain) on Equity Investments
---16.0116.281.83
Stock-Based Compensation
14.3620.7267.2754.8246.8435.74
Other Operating Activities
---47.45-0.97-1.08-9.88
Change in Accounts Receivable
-5-5---
Change in Accounts Payable
-1.9-17.32-18.0210.9215.5313.96
Change in Other Net Operating Assets
0.363.196.48-5.06-2.282.64
Operating Cash Flow
-128.1-125.25-170.86-207.82-163.75-154.09
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.03--0.22-0.58-2.55-6.11
Sale of Property, Plant & Equipment
0.130.70.07---
Divestitures
------14.32
Investment in Securities
120.71130.93176.72-43.88-111.632.31
Investing Cash Flow
120.81131.62176.56-44.46-114.18-18.12

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
5.95.690.35237.3261.04179.67
Repurchase of Common Stock
-11.43-9.98-0.24---1.15
Financing Cash Flow
-5.53-4.280.11237.3261.04178.52

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-12.822.095.81-14.98-16.896.31

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-128.13-125.25-171.08-208.41-166.3-160.2
Free Cash Flow Growth
------
Free Cash Flow Margin
---253.74%---
Free Cash Flow Per Share
-1.80-1.74-2.41-3.19-3.15-3.75
Levered Free Cash Flow
-79.45-75.87-67.1-86.97-88.02-89.16
Unlevered Free Cash Flow
-79.45-75.87-67.1-86.97-88.02-89.16

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
0.090.090.360.140.010.02
Change in Working Capital
-1.55-9.12-16.545.8613.2516.61
SEC Filings: 10-K · 10-Q